Literature DB >> 11166860

DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice.

A Henke1, R Zell, A Stelzner.   

Abstract

DNA immunizations with the major structural protein VP1 of Coxsackie virus B3 (CVB3) have been previously found to protect BALB/c mice from lethal challenge. Here we report that the other CVB3 capsid proteins, VP2, VP3, and VP4, were less effective at preventing CVB3-caused disease. The application of pCMV/VP1 as a vaccine caused decreased myocyte destruction, reduced viral load in the heart tissue, accelerated antibody induction, and an early cytokine expression in heart tissue. In summary, our results indicate that the induction of B cell and/or T cell memory in vaccinated mice prior to challenge is responsible for the protection observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166860     DOI: 10.1016/s0166-3542(00)00132-7

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  9 in total

1.  Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis.

Authors:  Dafei Chai; Yan Yue; Wei Xu; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2014-03-10       Impact factor: 3.452

2.  Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.

Authors:  A Henke; R Zell; G Ehrlich; A Stelzner
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model.

Authors:  Yeon-Jung Kim; Jeonghyun Ahn; Soo-Young Jeung; Dae-Sun Kim; Ha-Na Na; Young-Joo Cho; Soo-Hyeon Yun; Youngmee Jee; Eun-Seok Jeon; Heuiran Lee; Jae-Hwan Nam
Journal:  Virus Genes       Date:  2008-01-03       Impact factor: 2.332

4.  Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis.

Authors:  Xingmei Qi; Sidong Xiong
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

5.  AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.

Authors:  Liang Yin; Dafei Chai; Yan Yue; Chunsheng Dong; Sidong Xiong
Journal:  Front Cell Infect Microbiol       Date:  2017-06-08       Impact factor: 5.293

6.  Right Cervical Vagotomy Aggravates Viral Myocarditis in Mice Via the Cholinergic Anti-inflammatory Pathway.

Authors:  Ge Li-Sha; Chen Xing-Xing; Wu Lian-Pin; Zhou De-Pu; Li Xiao-Wei; Lin Jia-Feng; Li Yue-Chun
Journal:  Front Pharmacol       Date:  2017-01-31       Impact factor: 5.810

7.  Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis.

Authors:  Ge Li-Sha; Chen Yi-He; Zhou Na-Dan; Zhang Teng; Li Yue-Chun
Journal:  BMC Cardiovasc Disord       Date:  2013-11-14       Impact factor: 2.298

8.  A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis.

Authors:  Fei Wu; Xingjuan Fan; Yan Yue; Sidong Xiong; Chunsheng Dong
Journal:  Vaccine       Date:  2014-05-27       Impact factor: 3.641

9.  VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment.

Authors:  Fang-Hong Chen; Xiong Liu; Hua-Li Fang; Nan Nan; Zhan Li; Nian-Zhi Ning; De-Yan Luo; Tao Li; Hui Wang
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.